Beyond Air 10-Q: $16.3M Six-Month Loss, Going-Concern Warning, $13.7M Cash
XAIR is trading near its 52-week low of $2.05 (2.4% below the low) on elevated volume (3.0× avg).
Summary
Beyond Air's Q2 FY2027 10-Q shows a $16.3 million six-month net loss, $10.5 million of operating cash burn and a going-concern warning, with only $13.7 million of cash and securities on hand against $21.982 million of net long-term debt.
Key Events · Earnings and Guidance · XAIR
-
Going-Concern Warning Disclosed
Management concluded the Company will require additional funding within one year of the financial statements' issuance date, citing expected net losses and significant cash outflows for at least the next year.
-
Cash Burn Outpaces Balance Sheet
Operating activities used $10.5 million in the six months ended September 30, 2026, against $13.7 million of cash, cash equivalents and marketable securities and a $335.3 million accumulated deficit.
-
Q2 Loss Narrows, Gross Profit Turns Positive
Revenue rose to $2.324 million from $1.818 million a year earlier and gross profit reached $0.197 million versus a $0.298 million gross loss; net loss was $8.175 million for the quarter and $16.329 million for six months.
-
NeuroNOS Israel Sale Pending
The UNIVO transaction is classified as held for sale with $3.024 million of assets and $0.759 million of liabilities, expected to close December 2026, and carries up to $32.5 million in contingent milestone payments.
Analysis · XAIR · Industrial Applications And Services
The fiscal Q2 10-Q makes explicit what the preannouncement did not: management concluded the Company will require additional funding within one year of issuance, a substantial-doubt going-concern statement. With $10.5 million of operating cash burned in the six months to September 30 and $13.7 million held in cash, equivalents and marketable securities, the runway is short and another raise is near-certain. Revenue is improving — $2.324 million for the quarter versus $1.818 million a year ago, with a small $0.197 million gross profit — but the $8.175 million quarterly net loss and $21.982 million of net long-term debt swamp that progress. The NeuroNOS Israel sale to UNIVO, expected to close in December 2026, would remove $3.024 million of held-for-sale assets and bring UNIVO equity plus up to $32.5 million of contingent milestones, but none of that is cash in hand yet.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, XAIR was trading at $2.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4M. The 52-week trading range was $2.05 to $53.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.